Top

Published in:

01-04-2019 | Literatur kommentiert

Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom

Author: Prof. Dr. med. Matthias Guckenberger

Published in: Strahlentherapie und Onkologie | Issue 4/2019

Auszug

Präklinische und retrospektive klinische Daten generierten die Hypothese, dass auch im metastasierten Stadium des Prostatakarzinoms eine lokale Therapie der Prostata das Überleben verbessern kann. …

Méjean A et al (2018) Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 379:417–427CrossRefPubMed

Kaplan RN et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827CrossRefPubMedPubMedCentral

Gundem G et al (2015) The evolutionary history of lethal metastatic prostate cancer. Nature 520:353–357CrossRefPubMedPubMedCentral

Culp SH, Schellhammer PF, Williams MB (2014) Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 65:1058–1066CrossRefPubMed

Löppenberg B et al (2017) The impact of local treatment on overall survival in patients with metastatic prostate cancer on diagnosis: A national cancer data base analysis. Eur Urol 72:14–19CrossRefPubMed

Rusthoven CG et al (2016) Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer. J Clin Oncol 34:2835–2842CrossRefPubMed

Leyh-Bannurah S‑R et al (2017) Local therapy improves survival in metastatic prostate cancer. Eur Urol 72:118–124CrossRefPubMed

Parker CC et al (2018) Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): A randomised controlled phase 3 trial. Lancet 392:2353–2366CrossRefPubMedPubMedCentral

Boevé LMS et al (2018) Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary Bone metastatic prostate cancer in a prospective Randomised clinical trial: Data from the HORRAD trial. Eur Urol. https://doi.org/10.1016/j.eururo.2018.09.008 CrossRefPubMed

10.

Antonia SJ et al (2018) Overall survival with Durvalumab after Chemoradiotherapy in stage III NSCLC. N Engl J Med 379:2342–2350CrossRefPubMed

11.

Pompe RS et al (2018) Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages. Prostate 78:753–757CrossRefPubMed

12.

Wong HS et al (2018) Comparative study between 68 Ga-prostate-specific membrane antigen positron emission tomography and conventional imaging in the initial staging of prostate cancer. J Med Imaging Radiat Oncol 62:816–822CrossRefPubMed

13.

Dyrberg E et al (2018) 68 Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study. Eur Radiol. https://doi.org/10.1007/s00330-018-5682-x CrossRefPubMed

14.

Gravis G et al (2018) Burden of metastatic castrate naive prostate cancer patients, to identify men more likely to benefit from early Docetaxel: Further analyses of CHAARTED and GETUG-AFU15 studies. Eur Urol 73:847–855CrossRefPubMedPubMedCentral

15.

James ND et al (2017) Abiraterone for prostate cancer not previously treated with hormone therapy. N Engl J Med 377:338–351CrossRefPubMedPubMedCentral

16.

Ost P et al (2017) Surveillance or metastasis-directed therapy for Oligometastatic prostate cancer recurrence: A prospective, randomized, Multicenter phase II trial. J Clin Oncol 36:446–453CrossRefPubMed

17.

Donovan JL et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375:1425–1437CrossRefPubMedPubMedCentral

Title: Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom
Author: Prof. Dr. med. Matthias Guckenberger
Publication date: 01-04-2019
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 4/2019
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-019-01435-8

At a glance: The STEP trials

Springer Medicine

Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom

Auszug

At a glance: The STEP trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 4/2019

Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease

Management immunologischer Nebenwirkungen von Patienten, die mit Immun-Checkpoint-Inhibitoren behandelt werden: ASCO Clinical Practice Guideline Summary

Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study

Reply to the letter to the editor “Comment to ‘Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials’”

Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer

Functional recovery after surgical stabilization and postoperative radiotherapy due to metastases of long bones